Delivery Order SPE2DX22D0010-SPE2D826FBQ18
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,642.22 for Nucynta Tabs 75mg, a pain management pharmaceutical, by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- AmerisourceBergen Drug Corp received a delivery order award for Nucynta Tabs 75mg, a pain management pharmaceutical, valued at $12,160.31 with a firm fixed price structure. The contract was competitively awarded without a set-aside designation and will be completed by November 18, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal procurement entity, with the place of performance at AmerisourceBergen's corporate office in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This competitively awarded, non-set-aside contract carries a ceiling value of $12,375.14 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed price delivery order, valued at $10,788.15 with completion targeted for December 5, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,895.80 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by October 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,230.11 for Nucynta Tabs 100mg on August 21, 2025. This firm fixed-price contract, which has no set-aside designation, was funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the awardee's Conshohocken facility, with an ultimate completion date of August 22, 2025. The delivery order represents a short-duration...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,558.60 for Nucynta Tabs 100mg on December 3, 2025, with an ultimate completion date of December 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is funded through the Department of Defense Medical Supply Chain. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,789.57 for 100 tablets of Nucynta 75 mg on September 2, 2025, with completion targeted for September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical procurement...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,802.98 firm fixed price delivery order is for the supply of Nucynta Tablets 75mg, a prescription pain medication. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 25, 2025, for the supply of Nucynta ER Tablets 100mg with a ceiling value of $12,560.28. The competitively awarded, firm fixed-price delivery order is funded by the Defense Department's Medical Supply Chain and is due for completion by November 26, 2025. This award represents a child contract issued under AmerisourceBergen's larger Indefinite...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBQ18Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order for Nucynta Tabs 75mg valued at $7,937.42 by the Defense Logistics Agency's Medical Supply Chain on December 9, 2025, with completion anticipated by December 10, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, which serves as the vendor's corporate headquarters and a key distribution point for federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals, medical devices, and healthcare commodities to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen demonstrates significant capability in fulfilling diverse pharmaceutical supply requirements across multiple therapeutic domains through both small-value transactions and large-scale federal procurement initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 12/8/25 |